Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese mice

by Ulrika Edvardsson, Monica Bergström, Maria Alexandersson, Krister Bamberg, Bengt Ljung, Björn Dahllöf
Published 1999-07-01

PPARα activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes

by Ulrika Edvardsson, Anna Ljungberg, Daniel Lindén, Lena William-Olsson, Helena Peilot-Sjögren, Andrea Ahnmark, Jan Oscarsson
Published 2006-02-01